Cascadian Therapeutics, Inc. (CASC)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

2011-94TH STREET EDMONTON ALBERTA CAN, ALBERTA, CANADA 19899-1709

Oncothyreon Inc. researches and develops products to treat cancer; focused on core competency in immunotherapeutics. Its lead cancer vaccine candidate under clinical development is a synthetic Mucin 1 peptide vaccine, BLP25 liposome vaccine (L-BLP25).

Are you looking for these stocks instead?

View SEC Filings from CASC instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CASC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CASC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HENNEY CHRISTOPHER S

  • Director
No longer subject to file 2018-03-09 0

EASTLAND JULIA MARIE CFO & CBO

  • Officer
No longer subject to file 2018-03-09 0

CHRISTIANSON GARY CHIEF OPERATING OFFICER

  • Officer
No longer subject to file 2018-03-09 0

SPIEGELMAN DANIEL K

  • Director
No longer subject to file 2018-03-09 0

PETERSON SCOTT ROBERT CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2018-03-09 0

LOVE TED W

  • Director
No longer subject to file 2018-03-09 0

JAMES STEVEN P

  • Director
No longer subject to file 2018-03-09 0

FYFE GWEN A.

  • Director
No longer subject to file 2018-03-09 0

MYERS SCOTT DUNSETH PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2018-03-09 0

GROWTH EQUITY OPPORTUNITIES IV, LLC

NEW ENTERPRISE ASSOCIATES 15, L.P.

NEA PARTNERS 15, L.P.

NEA 15 GP, LLC

  • 10% Owner
No longer subject to file 2018-03-09 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
No longer subject to file 2018-03-09 0

BASKETT FOREST

  • 10% Owner
No longer subject to file 2018-03-09 0

BARRIS PETER J

  • 10% Owner
No longer subject to file 2018-03-09 0

VISWANATHAN RAVI

  • 10% Owner
No longer subject to file 2018-03-09 0

SONSINI PETER W.

  • 10% Owner
No longer subject to file 2018-03-09 0

SANDELL SCOTT D

  • 10% Owner
No longer subject to file 2018-03-09 0

SAKODA JON

  • 10% Owner
No longer subject to file 2018-03-09 0

MAKOWER JOSHUA

  • 10% Owner
No longer subject to file 2018-03-09 0

MOTT DAVID M

  • 10% Owner
No longer subject to file 2018-03-09 0

WALKER LUKE NATHANIEL SVP, CLINICAL DEVELOPMENT

  • Officer
No longer subject to file 2018-03-09 0

AZELBY ROBERT

  • Director
No longer subject to file 2018-03-09 0

JACKSON RICHARD L.

  • Director
11,968 2016-12-31 0

LAMPERT MARK N

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

  • Director
  • 10% Owner
18,799,368 2016-06-23 0

KIRKMAN ROBERT L PRESIDENT & CEO

  • Officer
  • Director
0 2015-09-24 0

HAUSMAN DIANA CHIEF MEDICAL OFFICER

  • Officer
0 2015-09-24 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
No longer subject to file 2015-02-05 0

VENKATESAN JAY EVP AND GENERAL MANAGER

  • Officer
0 2014-12-16 0

STOUGHTON W. VICKERY

  • Director
46,692 2014-06-06 0

WILLIAMS DOUGLAS E

  • Director
0 2013-06-13 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

INVESTMENT 10 LLC

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
7,837,978 2013-06-04 0

AYER CAPITAL MANAGEMENT, LP

  • 10% Owner
No longer subject to file 2011-06-23 0

AYER CAPITAL MANAGEMENT, LP

AYER CAPITAL PARTNERS, LLC

ACM CAPITAL PARTNERS, LLC

VENKATESAN JAY

  • 10% Owner
3,126,188 2011-05-21 0

KARAN SHASHI K. CORPORATE CONTROLLER

  • Officer
10,100 2010-09-28 0

TAYLOR EDWARD A. CFO, VP FIN & ADMIN, SEC

  • Officer
0 2008-06-04 0

KIRKPATRICK LYNN CHIEF SCIENTIFIC OFFICER

  • Officer
0 2008-06-04 0

BURLEY STEPHEN

  • Director
0 2008-06-04 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments